🎉 M&A multiples are live!
Check it out!

Getinge Valuation Multiples

Discover revenue and EBITDA valuation multiples for Getinge and similar public comparables like InfuSystem, Myomo, and Philips.

Getinge Overview

About Getinge

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.


Founded

1904

HQ

Sweden
Employees

11.8K+

Website

getinge.com

Financials

LTM Revenue $3.5B

LTM EBITDA $680M

EV

$6.0B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Getinge Financials

Getinge has a last 12-month revenue of $3.5B and a last 12-month EBITDA of $680M.

In the most recent fiscal year, Getinge achieved revenue of $3.5B and an EBITDA of $527M.

Getinge expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Getinge valuation multiples based on analyst estimates

Getinge P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $3.2B $3.5B XXX XXX XXX
Gross Profit $1.3B $1.4B XXX XXX XXX
Gross Margin 42% 42% XXX XXX XXX
EBITDA $586M $527M XXX XXX XXX
EBITDA Margin 19% 15% XXX XXX XXX
Net Profit $247M $240M XXX XXX XXX
Net Margin 8% 7% XXX XXX XXX
Net Debt n/a $384M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Getinge Stock Performance

As of April 15, 2025, Getinge's stock price is SEK 195 (or $19).

Getinge has current market cap of SEK 53.1B (or $5.3B), and EV of SEK 60.9B (or $6.0B).

See Getinge trading valuation data

Getinge Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$6.0B $5.3B XXX XXX XXX XXX $1.17

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Getinge Valuation Multiples

As of April 15, 2025, Getinge has market cap of $5.3B and EV of $6.0B.

Getinge's trades at 1.7x LTM EV/Revenue multiple, and 8.9x LTM EBITDA.

Analysts estimate Getinge's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Getinge and 10K+ public comps

Getinge Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $6.0B XXX XXX XXX
EV/Revenue 1.8x XXX XXX XXX
EV/EBITDA 11.5x XXX XXX XXX
P/E 32.4x XXX XXX XXX
P/E/Growth 0.7x XXX XXX XXX
EV/FCF 18.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Getinge Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Getinge Valuation Multiples

Getinge's NTM/LTM revenue growth is 5%

Getinge's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Getinge's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Getinge's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Getinge and other 10K+ public comps

Getinge Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 9% XXX XXX XXX XXX
EBITDA Margin 15% XXX XXX XXX XXX
EBITDA Growth -10% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 20% XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 15% XXX XXX XXX XXX
G&A Expenses to Revenue 12% XXX XXX XXX XXX
R&D Expenses to Revenue 4% XXX XXX XXX XXX
Opex to Revenue 36% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Getinge Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Getinge M&A and Investment Activity

Getinge acquired  XXX companies to date.

Last acquisition by Getinge was  XXXXXXXX, XXXXX XXXXX XXXXXX . Getinge acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Getinge

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Getinge

When was Getinge founded? Getinge was founded in 1904.
Where is Getinge headquartered? Getinge is headquartered in Sweden.
How many employees does Getinge have? As of today, Getinge has 11.8K+ employees.
Who is the CEO of Getinge? Getinge's CEO is Mr. Mattias Perjos.
Is Getinge publicy listed? Yes, Getinge is a public company listed on STO.
What is the stock symbol of Getinge? Getinge trades under GETI B ticker.
When did Getinge go public? Getinge went public in 1998.
Who are competitors of Getinge? Similar companies to Getinge include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Getinge? Getinge's current market cap is $5.3B
What is the current revenue of Getinge? Getinge's last 12-month revenue is $3.5B.
What is the current EBITDA of Getinge? Getinge's last 12-month EBITDA is $680M.
What is the current EV/Revenue multiple of Getinge? Current revenue multiple of Getinge is 1.7x.
What is the current EV/EBITDA multiple of Getinge? Current EBITDA multiple of Getinge is 8.9x.
What is the current revenue growth of Getinge? Getinge revenue growth between 2023 and 2024 was 9%.
Is Getinge profitable? Yes, Getinge is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.